Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.35 Analyst target: $8.44 Upside: 2322.50%
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company is headquartered in Watertown, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.